Implications of placebo and nocebo effects for clinical practice: Expert consensus
JournalPsychotherapy and Psychosomatics
PublisherS. Karger AG
MetadataShow full item record
AbstractBackground: Placebo and nocebo effects occur in clinical or laboratory medical contexts after administration of an inert treatment or as part of active treatments and are due to psychobiological mechanisms such as expectancies of the patient. Placebo and nocebo studies have evolved from predominantly methodological research into a far-reaching interdisciplinary field that is unravelling the neurobiological, behavioural and clinical underpinnings of these phenomena in a broad variety of medical conditions. As a consequence, there is an increasing demand from health professionals to develop expert recommendations about evidence-based and ethical use of placebo and nocebo effects for clinical practice. Methods: A survey and interdisciplinary expert meeting by invitation was organized as part of the 1st Society for Interdisciplinary Placebo Studies (SIPS) conference in 2017. Twenty-nine internationally recognized placebo researchers participated. Results: There was consensus that maximizing placebo effects and minimizing nocebo effects should lead to better treatment outcomes with fewer side effects. Experts particularly agreed on the importance of informing patients about placebo and nocebo effects and training health professionals in patient-clinician communication to maximize placebo and minimize nocebo effects. Conclusions: The current paper forms a first step towards developing evidence-based and ethical recommendations about the implications of placebo and nocebo research for medical practice, based on the current state of evidence and the consensus of experts. Future research might focus on how to implement these recommendations, including how to optimize conditions for educating patients about placebo and nocebo effects and providing training for the implementation in clinical practice. Copyright 2018 S. Karger AG, Basel. Copyright: All rights reserved.
Evidence-based ethical recommendations
Identifier to cite or link to this itemhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85048528421&doi=10.1159%2f000490354&partnerID=40&md5=9695f138a9d2d482bd09b83248228235; http://hdl.handle.net/10713/9767
- What Should Clinicians Tell Patients about Placebo and Nocebo Effects? Practical Considerations Based on Expert Consensus.
- Authors: Evers AWM, Colloca L, Blease C, Gaab J, Jensen KB, Atlas LY, Beedie CJ, Benedetti F, Bingel U, Büchel C, Bussemaker J, Colagiuri B, Crum AJ, Finniss DG, Geers AL, Howick J, Klinger R, Meeuwis SH, Meissner K, Napadow V, Petrie KJ, Rief W, Smeets I, Wager TD, Wanigasekera V, Vase L, Kelley JM, Kirsch I, Consortium of Placebo Experts.
- Issue date: 2021
- The Placebo and Nocebo Phenomena: Their Clinical Management and Impact on Treatment Outcomes.
- Authors: Chavarria V, Vian J, Pereira C, Data-Franco J, Fernandes BS, Berk M, Dodd S
- Issue date: 2017 Mar
- The Role of Patient-Practitioner Relationships in Placebo and Nocebo Phenomena.
- Authors: Blasini M, Peiris N, Wright T, Colloca L
- Issue date: 2018
- [The role of placebo and nocebo mechanisms in depressive diseases and their treatment].
- Authors: Rief W
- Issue date: 2020 Aug
- European Headache Federation recommendations for placebo and nocebo terminology.
- Authors: Mitsikostas DD, Blease C, Carlino E, Colloca L, Geers AL, Howick J, Evers AWM, Flaten MA, Kelley JM, Kirsch I, Klinger R, MaassenVanDenBrink A, Moerman DE, Sfikakis PP, Vase L, Wager TD, Benedetti F, European Headache Federation.
- Issue date: 2020 Sep 25